Beat to beat Ca2+-dependent regulation of pacemaker cell rate and rhythm
起搏细胞速率和节律的逐搏 Ca2 依赖性调节
基本信息
- 批准号:10913120
- 负责人:
- 金额:$ 41.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Action PotentialsAdrenergic ReceptorAgeAnimalsBehaviorBindingBiological PacemakersBrain DeathCardiovascular systemCell TherapyCellsCoupledCouplesCouplingCyclic AMPDevicesDiseaseElectrocardiogramFailureGenerationsHearingHeartHeart RateHourHumanIon ChannelKineticsLawsMembraneMolecularMusNaturePacemakersPeriodicityRegulationResearchRestSarcoplasmic ReticulumScientistSignal TransductionSinusSurfaceSystemTestingTimecostdesignimplantationin vivoinventionnew therapeutic targetnodal myocytevoltage
项目摘要
Failure of generation of automaticity and conduction of electrical activity within the heart becomes progressively more common as we age and is associated with a variety of cardiovascular and non-cardiovascular diseases. A major barrier to progress in the pacemaker field is a dearth of research in human hearts although the mouse has a resting heart rate of around 750 beats per minute while human resting heart rate is around 75. LCS Scientists built a team who are on call 24 hours/day, 7 days/week to respond with a regular supply of fresh human hearts from brain-dead donors. Similar to animals, a Ca2+ clock couples to a membrane clock to drive normal automaticity in single isolated human cardiac pacemaker cells. Clock uncoupling in human pacemaker cells as a putative mechanism of sinus node arrest, the endgame of human heart. These discoveries not only generalize the coupled-clock system paradigm from mice to humans but also led us to view clock coupling as a novel therapeutic target to develop a biological pacemaker. This cell-based therapy has a potential to reduce the necessity of conventional electrical pacemaker device implantation, which costs $24B annually in the USA alone.
Recently we discovered a long-range power law correlation between periodicity of cardiac pacemaker cell
clocks, heart rate and body mass: from mice to humans. Specifically, integrated local Ca2+
releases of Ca2+ clock during action potential (AP) ignition in single SAN cells, isolated from
diverse species (ranged from mouse to humans) not only scales linearly to the diverse range of
AP cycles across species in these cells, but also to EKG RR intervals in vivo, and furthermore
scales allometrically to the broad range of body masses across species. Such power law behavior is a manifestation of trans-species, self-ordered criticality of pacemaker cell molecular functions that regulate HR
In other terms, in designing appropriate hear rates to match body masses and energy requirements of different species from mouse to humans, nature did not re-invent the wheels but differentially scaled the gear kinetics that determine the rate at which the wheels spin.
随着年龄的增长,心脏内电活动的自动生成和传导失败变得越来越常见,并且与多种心血管和非心血管疾病相关。起搏器领域取得进展的一个主要障碍是缺乏对人类心脏的研究,尽管小鼠的静息心率约为每分钟 750 次,而人类的静息心率约为 75 次。LCS 科学家建立了一个 24 小时待命的团队每周 7 天、每天数小时,定期供应来自脑死亡捐献者的新鲜人类心脏。与动物类似,Ca2+时钟与膜时钟耦合,驱动单个分离的人类心脏起搏细胞的正常自动性。人类起搏细胞中的时钟解偶联是窦房结停搏(人类心脏的最后阶段)的假定机制。这些发现不仅将耦合时钟系统范式从小鼠推广到人类,而且使我们将时钟耦合视为开发生物起搏器的新治疗目标。这种基于细胞的疗法有可能减少传统电子起搏器植入的必要性,仅在美国每年的费用就高达 24B 美元。
最近我们发现心脏起搏细胞的周期性之间存在长程幂律相关性
时钟、心率和体重:从老鼠到人类。具体来说,整合局部 Ca2+
在单个 SAN 细胞的动作电位 (AP) 点火过程中释放 Ca2+ 时钟,与
不同的物种(从小鼠到人类)不仅线性地缩放到不同的范围
AP 在这些细胞中跨物种循环,而且还与体内 EKG RR 间隔相关,此外
异速生长地适应不同物种的广泛体重范围。这种幂律行为是调节 HR 的起搏细胞分子功能的跨物种、自序临界性的表现
换句话说,在设计适当的心率以匹配从老鼠到人类的不同物种的体重和能量需求时,大自然并没有重新发明轮子,而是对决定轮子旋转速度的齿轮动力学进行了差异化调整。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
cAMP-Dependent Signaling Restores AP Firing in Dormant SA Node Cells via Enhancement of Surface Membrane Currents and Calcium Coupling.
- DOI:10.3389/fphys.2021.596832
- 发表时间:2021
- 期刊:
- 影响因子:4
- 作者:Tsutsui K;Florio MC;Yang A;Wirth AN;Yang D;Kim MS;Ziman BD;Bychkov R;Monfredi OJ;Maltsev VA;Lakatta EG
- 通讯作者:Lakatta EG
Potential effects of intrinsic heart pacemaker cell mechanisms on dysrhythmic cardiac action potential firing.
内在心脏起搏器细胞机制对心律失常心脏动作电位放电的潜在影响。
- DOI:10.3389/fphys.2015.00047
- 发表时间:2015
- 期刊:
- 影响因子:4
- 作者:Yaniv,Yael;Tsutsui,Kenta;Lakatta,EdwardG
- 通讯作者:Lakatta,EdwardG
The end effector of circadian heart rate variation: the sinoatrial node pacemaker cell.
- DOI:10.5483/bmbrep.2015.48.12.061
- 发表时间:2015-12
- 期刊:
- 影响因子:3.8
- 作者:Yaniv Y;Lakatta EG
- 通讯作者:Lakatta EG
Impaired signaling intrinsic to sinoatrial node pacemaker cells affects heart rate variability during cardiac disease.
窦房结起搏细胞固有的信号受损会影响心脏病期间的心率变异性。
- DOI:10.4172/2167-0870.1000152
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Yaniv,Yael;Lyashkov,AlexeyE;Lakatta,EdwardG
- 通讯作者:Lakatta,EdwardG
From two competing oscillators to one coupled-clock pacemaker cell system.
- DOI:10.3389/fphys.2015.00028
- 发表时间:2015
- 期刊:
- 影响因子:4
- 作者:Yaniv Y;Lakatta EG;Maltsev VA
- 通讯作者:Maltsev VA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward Lakatta其他文献
Edward Lakatta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward Lakatta', 18)}}的其他基金
Decreased pacemaker activity in aged sinoatrial node
老年窦房结起搏器活动减少
- 批准号:
8335801 - 财政年份:
- 资助金额:
$ 41.66万 - 项目类别:
Soluble Receptor for Advanced Glycation End Products for Therapeutic Application
用于治疗应用的高级糖基化终产物的可溶性受体
- 批准号:
8552494 - 财政年份:
- 资助金额:
$ 41.66万 - 项目类别:
Therapeutic Potential of EPO and its Derivatives for Reducing Blood Pressure
EPO 及其衍生物降低血压的治疗潜力
- 批准号:
9147229 - 财政年份:
- 资助金额:
$ 41.66万 - 项目类别:
Effects Of Age And Conditioning Status On Rest And Exercise Cardiac Performance
年龄和体能状态对休息和运动心脏功能的影响
- 批准号:
8931601 - 财政年份:
- 资助金额:
$ 41.66万 - 项目类别:
Matching ATP supply and demand in cardiac pacemaker cells
匹配心脏起搏细胞中的 ATP 供应和需求
- 批准号:
8931611 - 财政年份:
- 资助金额:
$ 41.66万 - 项目类别:
PDE3, PDE4 and PKC regulate local Ca2+ releases and cardiac pacemaker firing
PDE3、PDE4 和 PKC 调节局部 Ca2 释放和心脏起搏器放电
- 批准号:
8736511 - 财政年份:
- 资助金额:
$ 41.66万 - 项目类别:
Age-Associated Changes in Arterial Proteome and Aortic Smooth Muscle Signaling
动脉蛋白质组和主动脉平滑肌信号与年龄相关的变化
- 批准号:
8931487 - 财政年份:
- 资助金额:
$ 41.66万 - 项目类别:
相似国自然基金
内皮β3肾上腺素能受体调控线粒体功能参与血管衰老的作用研究
- 批准号:82370408
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
肾上腺素能受体激动剂引起睑板腺功能障碍发病的机制研究
- 批准号:82371024
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
α1-和β3-肾上腺素能受体的荧光探针可视化研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
β2肾上腺素能受体调控皮肤角化细胞活化在慢性重叠型疼痛状态中的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
苯乙酰谷氨酰胺通过beta-2肾上腺素能受体调节小胶质细胞活化参与糖尿病视网膜病变炎症的机制研究
- 批准号:82171071
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Sympathetic neural patterns and transduction in obesity-associated hypertension
肥胖相关高血压的交感神经模式和转导
- 批准号:
10877436 - 财政年份:2023
- 资助金额:
$ 41.66万 - 项目类别:
Sympathetic neural patterns and transduction in obesity-associated hypertension
肥胖相关高血压的交感神经模式和转导
- 批准号:
10247728 - 财政年份:2020
- 资助金额:
$ 41.66万 - 项目类别:
Sympathetic neural patterns and transduction in obesity-associated hypertension
肥胖相关高血压的交感神经模式和转导
- 批准号:
10039251 - 财政年份:2020
- 资助金额:
$ 41.66万 - 项目类别:
Myocyte Repolarization and Cardiac Dysfunction with Age
随年龄增长的心肌细胞复极化和心脏功能障碍
- 批准号:
10180825 - 财政年份:2018
- 资助金额:
$ 41.66万 - 项目类别:
Myocyte Repolarization and Cardiac Dysfunction with Age
随年龄增长的心肌细胞复极化和心脏功能障碍
- 批准号:
9920638 - 财政年份:2018
- 资助金额:
$ 41.66万 - 项目类别: